Tag: ex vivo skin model

PRESS RELEASE - Salem, MA, USA - October 3rd, 2023 Genoskin Introduces ImmunoSafe: ISR Platform® with AUDACY - A Revolutionary Leap in Non-Clinical Local Toxicity Assessment Salem, MA, October 3rd, 2023 - Genoskin, a biotechnology company at the forefront of accelerating drug development, proudly announces the enhancement of its ISR Platform® with the integration of AUDACY, a state-of-the-art bioinformatics-based analyticalRead more

Genoskin launches new OncoSkin® skin cancer model at Meet2Win Genoskin has developed a new skin cancer model for the in vitro study of melanoma. Patients who suffer from this highly dangerous type of skin cancer currently have limited therapeutic options when the cancer reaches metastasis. The OncoSkin® skin cancer model now enables in vitro studies on live melanoma spheroids implanted

Read more

Genoskin will present its technology NativeSkin® at the Cosminnov 2013 congress organized in Orléans, France on October 8th and 9th. Importantly, two of our partners,